Considerations for DMD Gene Transfer Therapy

Pediatric neurologist Dr. John Brandsema discusses the implications of potentially having gene therapy for Duchenne Muscular Dystrophy (DMD) available in clinics. Learn about what experts are doing to address the challenges associated with gene transfer therapy as a clinical team in conjunction with patient support structures.

DMD Conference Coverage Playlist ➤    • DMD Conference Coverage  

This education is brought to you by the France Foundation and supported by an educational grant from Sarepta Therapeutics Inc. All information is intended for healthcare professionals.